•
Dec 31, 2024

Ryan Specialty Group Q4 2024 Earnings Report

Ryan Specialty reported strong revenue growth but faced a decline in net income for Q4 2024.

Key Takeaways

Ryan Specialty Holdings reported a 24.5% year-over-year increase in revenue to $663.5 million. However, net income fell by 27.3% to $42.6 million due to higher expenses. Adjusted net income rose by 28.9% to $123.3 million, and adjusted diluted EPS increased to $0.45. The company also achieved an 11.0% organic revenue growth rate.

Revenue grew 24.5% year-over-year to $663.5 million.

Net income declined 27.3% to $42.6 million due to increased expenses.

Adjusted net income increased 28.9% to $123.3 million.

Organic revenue growth rate was 11.0% for the quarter.

Total Revenue
$664M
Previous year: $533M
+24.5%
EPS
$0.45
Previous year: $0.35
+28.6%
Organic Revenue Growth Rate
11%
Previous year: 16.5%
-33.3%
Cash and Equivalents
$540M
Previous year: $839M
-35.6%
Total Assets
$9.65B
Previous year: $7.25B
+33.2%

Ryan Specialty Group

Ryan Specialty Group

Ryan Specialty Group Revenue by Segment

Forward Guidance

Ryan Specialty expects continued revenue growth in 2025, with organic revenue growth projected between 11.0% and 13.0%, and an adjusted EBITDAC margin of 32.5% to 33.5%.

Positive Outlook

  • Organic revenue growth guidance for FY25 is 11.0% - 13.0%.
  • Adjusted EBITDAC margin projected at 32.5% - 33.5%.
  • Continued expansion through M&A strategy.
  • Strong demand for specialty insurance products.
  • Operational efficiencies expected to support margin expansion.

Challenges Ahead

  • Higher operating expenses may impact profitability.
  • Interest expenses expected to remain elevated.
  • Macroeconomic uncertainties could affect growth.
  • Competitive pressures in the specialty insurance market.
  • Foreign exchange fluctuations could impact revenue.